Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-02-06 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
CdP FMR 240130.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Notification de transparence FMR LLC" and explicitly states it is an "Information réglementée" (Regulated Information). It details the acquisition of voting shares by FMR LLC, causing its stake to cross the 5% threshold on January 30, 2024. This content directly relates to changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is the most specific category available for this type of disclosure (crossing ownership thresholds).
2024-02-06 French
PB FMR 240130.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Transparantieverklaring FMR LLC" (Transparency Declaration FMR LLC) and explicitly states it is based on Article 14 of the law of May 2, 2007, regarding the disclosure of major shareholdings. It details the acquisition of UCB shares by FMR LLC, crossing the 5% threshold on January 30, 2024, and provides a breakdown of voting rights held by affiliated entities. This content directly corresponds to notifications about changes in significant share ownership levels, which matches the definition for Major Shareholding Notification (MRQ). Although it is a formal regulatory disclosure, MRQ is more specific than the general 'RNS' fallback.
2024-02-06 Dutch
PRWellingtonENG-171123.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Transparency notification" and explicitly states it is pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings. It details a notification received by UCB SA/NV from Wellington Management Group LLP regarding a decrease in their shareholding, crossing the 7.5% threshold downwards. This content directly relates to reporting changes in significant share ownership levels by an entity, which matches the definition for Major Shareholding Notification (MRQ). It is not an earnings release, annual report, or a general regulatory filing (RNS), as it concerns a specific insider/major shareholder transaction disclosure.
2023-11-23 English
CDPWellingtonFR-171123.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Notification de transparence Wellington" and explicitly states it is an "Information réglementée" (Regulated Information). The content details a change in shareholding percentage by Wellington Management Group LLP, crossing the 7.5% threshold, as required by the law of May 2, 2007, concerning the disclosure of major shareholdings. This type of filing, reporting changes in significant ownership stakes, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory announcement, MRQ is a more specific category than the general RNS.
2023-11-23 French
PBWellingtonNL-171123.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Transparantieverklaring Wellington" (Wellington Transparency Declaration) and explicitly states it is based on Article 14 of the law regarding the disclosure of major shareholdings ('openbaarmaking van belangrijke deelnemingen'). It details a change in the shareholding percentage of Wellington Management Group LLP in UCB NV, specifically noting that their stake dropped below the 7.5% threshold on November 17, 2023. This content directly corresponds to notifications about changes in significant share ownership levels, which matches the definition for Major Shareholding Notification (MRQ). Although it is a regulatory disclosure, MRQ is more specific than the general 'RNS' fallback.
2023-11-23 Dutch
Approval Zilu 18.10.23.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by UCB announcing the U.S. FDA approval of a new drug, ZILBRYSQ, for the treatment of generalized myasthenia gravis. It details the clinical trial results (RAISE study), the mechanism of action, and quotes from company leadership. As it is a general regulatory announcement regarding product approval and does not fit into specific financial reporting categories like 10-K or Earnings Release, it falls under the Regulatory Filings (RNS) category.
2023-10-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.